Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.
For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.
Supply chain resilience is essential to assure consumer healthcare products Americans depend on remain widely available, including in times of disease outbreaks or global crises.
Expert insights on the importance of proactive health maintenance, including addressing nutrient deficiencies that increase risk of infection and disease.
When used appropriately melatonin can play an important role in personal healthcare, but inappropriate use of supplements could be harmful. Consumers should be wary of dietary supplement products making unsubstantiated claims regarding the prevention and treatment of COVID-19.
CHPA released the following statement in response to ongoing efforts by the U.S. Food and Drug Administration (FDA) to keep hand sanitizers that contain harmful substances off the market.
